Authors:
THIRION S
MOTMANS K
HEYLIGEN H
JANSSENS J
RAUS J
VANDEVYVER C
Citation: S. Thirion et al., MONOSPECIFIC AND BISPECIFIC SINGLE-CHAIN ANTIBODY FRAGMENTS FOR CANCER-THERAPY, European journal of cancer prevention, 5(6), 1996, pp. 507-511
Authors:
MOTMANS K
THIRION S
HEYLIGEN H
JANSSENS J
RAUS J
VANDEVYVER C
Citation: K. Motmans et al., IMMUNOTHERAPY FOR CANCER - CONSTRUCTION, EXPRESSION AND FUNCTIONAL-CHARACTERIZATION OF CHIMERIC ANTIBODIES, European journal of cancer prevention, 5(6), 1996, pp. 512-519
Authors:
VANHAM G
KESTENS L
DEMEESTER I
VINGERHOETS J
PENNE G
VANHOOF G
SCHARPE S
HEYLIGEN H
BOSMANS E
CEUPPENS JL
GIGASE P
Citation: G. Vanham et al., DECREASED EXPRESSION OF THE MEMORY MARKER CD26 ON BOTH CD4-LYMPHOCYTES OF HIV-INFECTED SUBJECTS( AND CD8+ T), Journal of acquired immune deficiency syndromes, 6(7), 1993, pp. 749-757
Authors:
DEMEESTER I
SCHARPE S
VANHAM G
BOSMANS E
HEYLIGEN H
VANHOOF G
CORTE G
Citation: I. Demeester et al., ANTIBODY-BINDING PROFILE OF PURIFIED AND CELL-BOUND CD26 - DESIGNATION OF BT5 9 AND TA5.9 TO THE CD26 CLUSTER/, Immunobiology, 188(1-2), 1993, pp. 145-158
Authors:
VANDEVYVER C
STEUKERS M
LAMBRECHTS J
HEYLIGEN H
RAUS J
Citation: C. Vandevyver et al., DEVELOPMENT AND FUNCTIONAL-CHARACTERIZATION OF A MURINE HUMAN CHIMERIC ANTIBODY WITH SPECIFICITY FOR THE HUMAN INTERLEUKIN-2 RECEPTOR, Molecular immunology, 30(10), 1993, pp. 865-876